glp-1 drugs shortage Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s FDA says that the GLP-1

About one in eight adults (12%) say they have taken one of an increasingly popular class of prescription drugs known as GLP-1s that are used for weight loss and to treat diabetes and reduce the risk of heart disease and stroke, a new KFF Health Tracking Poll finds.

A limited exception to market exclusivity exists for drugs on the FDAs shortage list, which indicates a drug in low supply

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are a well-established class of glucose-lowering drugs

Companies operating in this space may benefit from reviewing their promotional materials to ensure alignment with FDA expectations

This hormone helps regulate blood sugar levels and induces a feeling of fullness, leading to reduced food intake

Youve likely heard about the incredible results of GLP-1 (glucagon-like peptide-1) medications, such as semaglutide, liraglutide, and tirzepatide, for